Lipoprotein(a) as a predictor of major adverse cardiovascular events in patients with very premature (≤40 years) acute coronary syndrome: long-term follow-up of the STudy of eArly Myocardial INfArction study
Elevated Lp(a) concentrations demonstrate an independent association with recurrent MACE among very young ACS survivors. Until targeted Lp(a)-lowering treatments become clinically available, an aggressive lipid-lowering approach may be warranted to partially attenuate Lp(a)-related residual cardiovascular risk.
Authors
- Stylianos Armylagos
- Christos Kotakos
- Stylianos L. Rallidis
- Konstantinos Papathanasiou
- Eleni P Stathopoulou
- Demosthenes Panagiotakos
- Sofia-Panagiota Giannakopoulou
- Loukianos S. Rallidis
Institutions
- University of Nicosia (CY)
- National and Kapodistrian University of Athens (GR)
- Hellenic Air Force (GR)
- Harokopio University of Athens (GR)
- University General Hospital Attikon (GR)
Publication Details
- Journal
- Coronary Artery Disease
- Published
- 2026-03-09
- DOI
- https://doi.org/10.1097/mca.0000000000001627
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00